Device Week, 10 March 2022 –Femtech Attracts Investors; ZimVie Fails To Impress

In this edition of Device Week, Medtech Insight’s Reed Miller chats with UK-based reporter Barnaby Pickering about Zimmer Biomet’s recent spin-off of its spinal and dental businesses under the name ZimVie, and Marion Webb explains the emerging field of femtech, which includes innovations to treat often-overlooked needs in women’s health. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: Zimmer Biomet Spin-Off’s Share Price Plummets https://medtech.pharmaintelligence.informa.com/MT145159/Zimmer-Biomet-Spin-Offs-Share-Price-Plummets ‘Femtech’ Evolving Beyond Periods, Pregnancy And Postpartum: What’s Next In $1.2Tr Women’s Health https://medtech.pharmaintelligence.informa.com/MT145121/Femtech-Evolving-Beyond-Periods-Pregnancy-And-Postpartum-Whats-Next-In-12Tr-Womens-Health